Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Clin Cancer Res. 2009 Feb 24;15(5):1645–1654. doi: 10.1158/1078-0432.CCR-08-2581

Fig. 4.

Fig. 4

Relations of recurrence to pretreatment Bcl-2 and Bcl-XL expression (cf. Table 1). Kaplan-Meier plots of disease-free survival, with times of last follow-up indicated by cross-marks. Bcl-2 expression was related to significantly increased risk of recurrence (A) whereas risk of recurrence was not related to Bcl-XL (B). See Table 1 and text for Cox proportional hazard analysis.